Preventive treatment of renal impairment and graft rejection in cardiac transplantation using cyclosporine with an oral prostaglandin analog.
Wahlers
T
T
Department Cardiothoracic and Vascular Surgery, Hannover Medical School, Germany.
Kotzerke
B
B
Wagenbreth
I
I
Hausen
B
B
Haverich
A
A
D000284:Administration, Oral; D000527:Alprostadil / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D001707:Biopsy, Needle; D016572:Cyclosporine / Q000009:adverse effects* / Q000627:therapeutic use; D006084:Graft Rejection / Q000517:prevention & control*; D016027:Heart Transplantation / Q000276:immunology* / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007668:Kidney / Q000187:drug effects* / Q000473:pathology; D007674:Kidney Diseases / Q000139:chemically induced / Q000517:prevention & control*; D011446:Prospective Studies
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D000527:Alprostadil; C054594:enisoprost